<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1995
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______ to ______
Commission File Number 0-17822
SYNETIC, INC.
(Exact name of registrant as specified in its charter)
Delaware 22-2975182
(State or other jurisdiction of (I.R.S Employer
incorporation or organization) Identification No.)
River Drive Center 2
669 River Drive
Elmwood Park, New Jersey 07407
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (201) 703-3400
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days. Yes X No ___
---
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
Class Outstanding at May 8,1995
- --------------------- -------------------------
Common Stock 16,579,737 shares par value
$.01 per share
<PAGE>
SYNETIC INC. AND SUBSIDIARIES
PART II. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.
(a) Exhibits
Exhibit No. Description
27 Financial Data Schedule
(b) On January 27, 1995, the Company filed a report on Form 8-K presenting
the consolidated financial statements of the Company, previously
included in the Company's Annual Report on Form 10-K for the fiscal
year ended June 30, 1994, restated to report separately the net assets
and operating results of the discontinued operations of the
institutional pharmacy business sold to Pharmacy Corporation of
America, an indirect wholly owned subsidiary of Beverly Enterprises,
Inc., on December 14, 1994.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SYNETIC, INC.
/s/ VICTOR L. MARRERO
--------------------------------
Victor L. Marrero
Vice President - Finance
and Chief Financial Officer
Dated: July 5, 1995
3
<PAGE>
EXHIBIT INDEX
Number Description
27 Financial Data Schedule
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SYNETIC
INC.'S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1995 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JUN-30-1995
<PERIOD-START> JUL-01-1994
<PERIOD-END> MAR-31-1995
<CASH> 5,700
<SECURITIES> 140,760
<RECEIVABLES> 6,753
<ALLOWANCES> 492
<INVENTORY> 6,212
<CURRENT-ASSETS> 113,421
<PP&E> 30,468
<DEPRECIATION> 13,719
<TOTAL-ASSETS> 180,216
<CURRENT-LIABILITIES> 10,103
<BONDS> 0
<COMMON> 218
0
0
<OTHER-SE> 161,714
<TOTAL-LIABILITY-AND-EQUITY> 180,216
<SALES> 28,288
<TOTAL-REVENUES> 28,288
<CGS> 16,875
<TOTAL-COSTS> 16,875
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,603
<INCOME-PRETAX> (2,571)
<INCOME-TAX> (970)
<INCOME-CONTINUING> (1,601)
<DISCONTINUED> 12,748
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 11,147
<EPS-PRIMARY> .65
<EPS-DILUTED> 0
</TABLE>
